Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hana Micron (067310) – Decision on Cash and In-Kind Dividend / 2025-03-11

Posted on March 11, 2025August 2, 2026 By K-STOCK Editor No Comments on [Disclosure] Hana Micron (067310) – Decision on Cash and In-Kind Dividend / 2025-03-11

Fact Source: Financial Supervisory Service DART

💡 Executive Summary

Hana Micron resolved to pay a year-end cash dividend for FY2024 of KRW 70 per common share, representing a dividend yield of 0.73% and a total payout of approximately KRW 4.64 billion.

📊 Key Disclosure Content & Financial Figures Summary

  1. Company Name: Hana Micron Inc.
  2. Dividend Type: Year-end dividend (Cash dividend)
  3. Dividend per Share: KRW 70 for common stock (No differential dividend)
  4. Dividend Yield: 0.73% for common stock (Base average price: KRW 9,615)
  5. Total Dividend Amount: KRW 4,639,036,430 (Based on 66,271,949 total issued shares)
  6. Record Date: December 31, 2024
  7. Expected General Meeting Date: March 28, 2025 (Approving Body: General Meeting of Shareholders)
  8. Board Resolution Date: March 11, 2025 (1 Outside Director attended, Auditor attended)
  9. Other References for Investment Decision:
    • Dividends will be paid within one month from the date of shareholder meeting approval.
    • Details may be subject to change during the general meeting approval process.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Shareholder Meeting Approval and Payment Schedule

This filing discloses the board’s proposal for the FY2024 year-end cash dividend payout. Confirming the final approval of the dividend proposal at the shareholder meeting and tracking the payout execution are important for assessing shareholder return implementation. Finalized details can be verified in subsequent official disclosures, including the Results of the Annual General Meeting of Shareholders.

📢 Disclaimer & Source Information

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Disclaimer: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial risks rest solely with the investor.

Contact: For compliance inquiries or copyright-related issues, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Hana Micron (067310) – Resolution on Convening General Meeting of Shareholders / 2025-03-11
Next Post: [Disclosure] Hana Micron (067310) – Change in Sales or Profit/Loss Structure by 30% or More / 2025-03-11

Related Posts

[Disclosure] Hyundai Motor (005380) – Decision on Quarterly Cash Dividend (KRW 2,500 per Share / Total KRW 654.59B) Disclosures
[Disclosure] LEENO Industrial (058470) – Decision on Cash/In-Kind Dividend / 2024-12-19 Semiconductors
[Disclosure] ISU PETASYS (007660) – Report on Reasons for Holding Annual General Meeting on Concentrated Date / 2024-03-14 Disclosures
[Disclosure] Celltrion (068270) – Approval of Korean MFDS Marketing Authorization for Avtozma Subcutaneous Injection (CT-P47, Actemra Biosimilar) / 2025-02-13 Disclosures
[Disclosure] SK Square (402340) – Decision on Paid-in Capital Increase / 2026-06-24 Semiconductors
[Disclosure] Samsung Electronics(005930) – Matters Related to Timely Disclosure Duty (Fair Disclosure) / 2024-01-31 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme